198 related articles for article (PubMed ID: 37158258)
41. MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer.
Sze CC; Shilatifard A
Cold Spring Harb Perspect Med; 2016 Nov; 6(11):. PubMed ID: 27638352
[TBL] [Abstract][Full Text] [Related]
42. DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation.
Godfrey L; Crump NT; Thorne R; Lau IJ; Repapi E; Dimou D; Smith AL; Harman JR; Telenius JM; Oudelaar AM; Downes DJ; Vyas P; Hughes JR; Milne TA
Nat Commun; 2019 Jun; 10(1):2803. PubMed ID: 31243293
[TBL] [Abstract][Full Text] [Related]
43. Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains.
Gopi LK; Kidder BL
Nat Commun; 2021 Mar; 12(1):1419. PubMed ID: 33658503
[TBL] [Abstract][Full Text] [Related]
44. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
45. Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer.
Han T; Lin J; Wang Y; Fan Q; Sun H; Tao Y; Sun C
Biomed Pharmacother; 2018 Jul; 103():1369-1375. PubMed ID: 29864920
[TBL] [Abstract][Full Text] [Related]
46. Cytosine modifications modulate the chromatin architecture of transcriptional enhancers.
Mahé EA; Madigou T; Sérandour AA; Bizot M; Avner S; Chalmel F; Palierne G; Métivier R; Salbert G
Genome Res; 2017 Jun; 27(6):947-958. PubMed ID: 28396520
[TBL] [Abstract][Full Text] [Related]
47. Rapid Enhancer Remodeling and Transcription Factor Repurposing Enable High Magnitude Gene Induction upon Acute Activation of NK Cells.
Sciumè G; Mikami Y; Jankovic D; Nagashima H; Villarino AV; Morrison T; Yao C; Signorella S; Sun HW; Brooks SR; Fang D; Sartorelli V; Nakayamada S; Hirahara K; Zitti B; Davis FP; Kanno Y; O'Shea JJ; Shih HY
Immunity; 2020 Oct; 53(4):745-758.e4. PubMed ID: 33010223
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
49. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
50. Integrated analysis of genes encoding ATP-dependent chromatin remodellers identifies CHD7 as a potential target for colorectal cancer therapy.
Zhang X; Zhou Y; Shi Z; Liu Z; Chen H; Wang X; Cheng Y; Xi L; Li X; Zhang C; Bao L; Xuan C
Clin Transl Med; 2022 Jul; 12(7):e953. PubMed ID: 35789070
[TBL] [Abstract][Full Text] [Related]
51. Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations.
Zhang Y; Wong CH; Birnbaum RY; Li G; Favaro R; Ngan CY; Lim J; Tai E; Poh HM; Wong E; Mulawadi FH; Sung WK; Nicolis S; Ahituv N; Ruan Y; Wei CL
Nature; 2013 Dec; 504(7479):306-310. PubMed ID: 24213634
[TBL] [Abstract][Full Text] [Related]
52. TGF-β-mediated Foxp3 gene expression is cooperatively regulated by Stat5, Creb, and AP-1 through CNS2.
Ogawa C; Tone Y; Tsuda M; Peter C; Waldmann H; Tone M
J Immunol; 2014 Jan; 192(1):475-83. PubMed ID: 24298014
[TBL] [Abstract][Full Text] [Related]
53. Loss of SUV420H2-Dependent Chromatin Compaction Drives Right-Sided Colon Cancer Progression.
Boonsanay V; Mosa MH; Looso M; Weichenhan D; Ceteci F; Pudelko L; Lechel A; Michel CS; Künne C; Farin HF; Plass C; Greten FR
Gastroenterology; 2023 Feb; 164(2):214-227. PubMed ID: 36402192
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
Gao F; Wang W
Mol Med Rep; 2015 Feb; 11(2):1200-6. PubMed ID: 25369914
[TBL] [Abstract][Full Text] [Related]
55. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification.
Samstein RM; Arvey A; Josefowicz SZ; Peng X; Reynolds A; Sandstrom R; Neph S; Sabo P; Kim JM; Liao W; Li MO; Leslie C; Stamatoyannopoulos JA; Rudensky AY
Cell; 2012 Sep; 151(1):153-66. PubMed ID: 23021222
[TBL] [Abstract][Full Text] [Related]
56. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
57. Obesity, rather than diet, drives epigenomic alterations in colonic epithelium resembling cancer progression.
Li R; Grimm SA; Chrysovergis K; Kosak J; Wang X; Du Y; Burkholder A; Janardhan K; Mav D; Shah R; Eling TE; Wade PA
Cell Metab; 2014 Apr; 19(4):702-11. PubMed ID: 24703701
[TBL] [Abstract][Full Text] [Related]
58. H3K4 monomethylation dictates nucleosome dynamics and chromatin remodeling at stress-responsive genes.
Nadal-Ribelles M; Mas G; Millán-Zambrano G; Solé C; Ammerer G; Chávez S; Posas F; de Nadal E
Nucleic Acids Res; 2015 May; 43(10):4937-49. PubMed ID: 25813039
[TBL] [Abstract][Full Text] [Related]
59. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
[TBL] [Abstract][Full Text] [Related]
60. Integrating epigenomic data and 3D genomic structure with a new measure of chromatin assortativity.
Pancaldi V; Carrillo-de-Santa-Pau E; Javierre BM; Juan D; Fraser P; Spivakov M; Valencia A; Rico D
Genome Biol; 2016 Jul; 17(1):152. PubMed ID: 27391817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
